| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 21,959 | 54,968 | 59,792 | | Cost of Revenue | 19,055 | 44,040 | 42,924 | | | Gross Profit | 2,904 | 10,928 | 16,868 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 15,119 | 18,928 | 14,422 | | Non Recurring |
-
|
-
|
-
| | Others | 1,951 | 1,866 | 1,164 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,165) | (9,867) | 1,282 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,009 | 41 | 257 | | Earnings Before Interest And Taxes | (10,156) | (9,826) | 1,540 | | Interest Expense | 1,688 | 608 |
-
| | Income Before Tax | (11,844) | (10,435) | 1,540 | | Income Tax Expense | (1,063) | (2,510) | 343 | | Minority Interest | 709 | 900 | 1,310 | | | | Net Income From Continuing Ops | (10,072) | (7,025) | 2,507 | | | Non-recurring Events | | Discontinued Operations | (15,991) | 8 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (26,064) | (7,017) | 2,507 | | Preferred Stock And Other Adjustments | (576) | (408) | (300) | | | Net Income Applicable To Common Shares | ($26,640) | ($7,425) | $2,207 |
|
0.02% Nasdaq 
0.05 (12.82%) 
Income Statement
